ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 90 filers reported holding ALLOVIR INC in Q1 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,900,973 | -36.8% | 4,605,104 | 0.0% | 0.02% | -33.3% |
| Q2 2023 | $15,657,353 | -13.7% | 4,605,104 | 0.0% | 0.03% | -32.5% |
| Q1 2023 | $18,144,109 | -23.2% | 4,605,104 | 0.0% | 0.04% | -56.0% |
| Q4 2022 | $23,624,184 | -39.2% | 4,605,104 | -6.5% | 0.09% | -27.8% |
| Q3 2022 | $38,843,000 | +261.6% | 4,923,104 | +78.8% | 0.13% | +334.5% |
| Q2 2022 | $10,741,000 | +111.1% | 2,753,909 | +265.3% | 0.03% | +190.0% |
| Q1 2022 | $5,089,000 | -48.7% | 753,909 | -1.6% | 0.01% | -44.4% |
| Q4 2021 | $9,913,000 | -63.8% | 766,020 | -29.9% | 0.02% | -60.9% |
| Q3 2021 | $27,404,000 | +27.0% | 1,093,520 | 0.0% | 0.05% | +43.8% |
| Q2 2021 | $21,586,000 | -15.9% | 1,093,520 | -0.3% | 0.03% | -15.8% |
| Q1 2021 | $25,670,000 | -39.1% | 1,097,000 | 0.0% | 0.04% | -44.9% |
| Q4 2020 | $42,168,000 | +39.8% | 1,097,000 | 0.0% | 0.07% | +23.2% |
| Q3 2020 | $30,167,000 | – | 1,097,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |